News HLB Therapeutics Co.,Ltd.

Equities

A115450

KR7115450009

End-of-day quote Korea S.E. Other stock markets 23:00:00 09/05/2024 BST			5-day change	1st Jan Change
9,340 ^KRW	-5.56%		-11.89%	+113.00%

04-01	HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd.	CI
03-18	HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd.	03-31	CI
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-18	CI
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
HLB Life Science Co., Ltd. announced that it has received KRW 8.3 billion in funding from HLB Therapeutics Co.,Ltd.	06/07/23	CI
HLB Life Science Co., Ltd. announced that it expects to receive KRW 8.3 billion in funding from HLB Therapeutics Co.,Ltd.	28/06/23	CI
Panagene Inc. announced that it expects to receive KRW 56.599994061 billion in funding from a group of investors	20/06/23	CI
Panagene Inc. announced that it expects to receive KRW 46.068324061 billion in funding from HLB Co., Ltd., HLB Investment Co., Ltd., HLB bioStep Co.,Ltd., HLB innoVation Co.,Ltd., HLB Therapeutics Co.,Ltd.	20/06/23	CI
HLB Therapeutics Co.,Ltd. announced that it has received KRW 2.5 billion in funding	15/06/23	CI
HLB Therapeutics Co.,Ltd. announced that it has received KRW 5 billion in funding	15/06/23	CI
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
RegeneRx Biopharmaceuticals, Inc. - First Patient Enrolled into U.S. Phase 3 Neurotrophic Keratitis Clinical trial with RGN-259	14/04/23	AQ
HLB innoVation Co.,Ltd. announced that it has received KRW 55.99999522 billion in funding from a group of investors	12/03/23	CI
Oblato, Inc. announced that it has received KRW 18.408 billion in funding from HLB Therapeutics Co.,Ltd.	13/02/23	CI
Oblato, Inc. announced that it expects to receive KRW 18.408 billion in funding from HLB Therapeutics Co.,Ltd.	05/02/23	CI
HLB innoVation Co.,Ltd. announced that it expects to receive KRW 55.99999522 billion in funding from a group of investors	31/01/23	CI
HLB Therapeutics Co.,Ltd. announced that it has received KRW 13.0088 billion in funding from HLB Co., Ltd.	11/01/23	CI
HLB Therapeutics to Raise 13 Billion Won via Stock Sale	04/01/23	MT
HLB Therapeutics Co.,Ltd. announced that it expects to receive KRW 13.0088 billion in funding from HLB Co., Ltd.	03/01/23	CI
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News HLB Therapeutics Co.,Ltd.

Equities

A115450

KR7115450009

Summary

Filters